133 related articles for article (PubMed ID: 1867955)
1. Interaction between 5-fluorouracil, [6RS]leucovorin, and recombinant human interferon-alpha 2a in cultured colon adenocarcinoma cells.
Houghton JA; Adkins DA; Rahman A; Houghton PJ
Cancer Commun; 1991 Jul; 3(7):225-31. PubMed ID: 1867955
[TBL] [Abstract][Full Text] [Related]
2. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.
Houghton JA; Morton CL; Adkins DA; Rahman A
Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921
[TBL] [Abstract][Full Text] [Related]
3. Influence of dose of [6RS]leucovorin on reduced folate pools and 5-fluorouracil-mediated thymidylate synthase inhibition in human colon adenocarcinoma xenografts.
Houghton JA; Williams LG; Cheshire PJ; Wainer IW; Jadaud P; Houghton PJ
Cancer Res; 1990 Jul; 50(13):3940-6. PubMed ID: 2354443
[TBL] [Abstract][Full Text] [Related]
4. A Fas-dependent component in 5-fluorouracil/leucovorin-induced cytotoxicity in colon carcinoma cells.
Tillman DM; Petak I; Houghton JA
Clin Cancer Res; 1999 Feb; 5(2):425-30. PubMed ID: 10037193
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of 5-fluorouracil-leucovorin activity by alpha2a-interferon in colon adenocarcinoma xenografts.
Houghton JA; Cheshire PJ; Morton CL; Stewart CF
Clin Cancer Res; 1995 Jan; 1(1):33-40. PubMed ID: 9815884
[TBL] [Abstract][Full Text] [Related]
6. Comparative cytotoxicity of folate-based inhibitors of thymidylate synthase and 5-fluorouracil +/- leucovorin in MGH-U1 cells.
Erlichman C; Mitrovski B
Cancer Chemother Pharmacol; 1994; 34(1):51-6. PubMed ID: 8174202
[TBL] [Abstract][Full Text] [Related]
7. Factors that influence the therapeutic activity of 5-fluorouracil [6RS]leucovorin combinations in colon adenocarcinoma xenografts.
Houghton JA; Williams LG; Loftin SK; Cheshire PJ; Morton CL; Houghton PJ; Dayan A; Jolivet J
Cancer Chemother Pharmacol; 1992; 30(6):423-32. PubMed ID: 1394798
[TBL] [Abstract][Full Text] [Related]
8. Combined modulation by leucovorin and alpha-2a interferon of fluoropyrimidine mediated growth inhibition.
Sinnige HA; Timmer-Bosscha H; Peters GF; De Vries EG; Mulder NH
Anticancer Res; 1993; 13(5A):1335-40. PubMed ID: 8239504
[TBL] [Abstract][Full Text] [Related]
9. Relationship between dose rate of [6RS]Leucovorin administration, plasma concentrations of reduced folates, and pools of 5,10-methylenetetrahydrofolates and tetrahydrofolates in human colon adenocarcinoma xenografts.
Houghton JA; Williams LG; de Graaf SS; Cheshire PJ; Rodman JH; Maneval DC; Wainer IW; Jadaud P; Houghton PJ
Cancer Res; 1990 Jun; 50(12):3493-502. PubMed ID: 2140289
[TBL] [Abstract][Full Text] [Related]
10. Enhanced cytotoxicity of 5-fluorouracil combined with [6RS]leucovorin and recombinant human interferon-alpha 2a in colon carcinoma cells.
Houghton JA; Adkins DA; Houghton PJ
Adv Exp Med Biol; 1993; 339():133-42; discussion 165-7. PubMed ID: 8178712
[No Abstract] [Full Text] [Related]
11. New therapeutic strategies for patients with gastrointestinal malignancies using biochemical modulation of fluorouracil.
Allegra CJ
JAMA; 1995 Jan; 273(3):236-9. PubMed ID: 7807664
[No Abstract] [Full Text] [Related]
12. Time dependence of DNA lesions and growth inhibition by ICI D1694, a new quinazoline antifolate thymidylate synthase inhibitor.
Yin MB; Guimaraes MA; Zhang ZG; Arredondo MA; Rustum YM
Cancer Res; 1992 Nov; 52(21):5900-5. PubMed ID: 1394217
[TBL] [Abstract][Full Text] [Related]
13. Biochemical modulation of fluorouracil with leucovorin and interferon: preclinical and clinical investigations.
Grem JL; Chu E; Boarman D; Balis FM; Murphy RF; McAtee N; Allegra CJ
Semin Oncol; 1992 Apr; 19(2 Suppl 3):36-44. PubMed ID: 1557656
[TBL] [Abstract][Full Text] [Related]
14. Mutation(s) of the thymidylate synthase gene of human adenocarcinoma cells causes a thymidylate synthase-negative phenotype that can be attenuated by exogenous folates.
Houghton PJ; Rahman A; Will CL; Dolnick BJ; Houghton JA
Cancer Res; 1992 Feb; 52(3):558-65. PubMed ID: 1732043
[TBL] [Abstract][Full Text] [Related]
15. [Augmentation of chemotherapeutic efficaciousness of UFT by oral l-leucovorin--l-leucovorin factors enhancing cytotoxic activity of 5-fluorouracil].
Yuasa C; Okabe H; Toko T; Takeda S; Unemi N
Gan To Kagaku Ryoho; 1995 Nov; 22(13):1927-32. PubMed ID: 7487122
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and pharmacologic basis for potentiation of 5-fluorouracil action by leucovorin.
Rustum YM; Trave F; Zakrzewski SF; Petrelli N; Herrera L; Mittelman A; Arbuck SG; Creaven PJ
NCI Monogr; 1987; (5):165-70. PubMed ID: 2448653
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of the antitumor activity of 5-fluorouracil in colon carcinoma cells by the combination of interferon and deoxyribonucleosides results from complementary effects on thymidine phosphorylase.
Schwartz EL; Baptiste N; O'Connor CJ; Wadler S; Otter BA
Cancer Res; 1994 Mar; 54(6):1472-8. PubMed ID: 8137250
[TBL] [Abstract][Full Text] [Related]
18. p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon carcinoma cell lines.
Petak I; Tillman DM; Houghton JA
Clin Cancer Res; 2000 Nov; 6(11):4432-41. PubMed ID: 11106264
[TBL] [Abstract][Full Text] [Related]
19. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of quinazoline antifolate (CB3717) toxicity by dipyridamole in human lung carcinoma, A549, cells.
Curtin NJ; Harris AL
Biochem Pharmacol; 1988 Jun; 37(11):2113-20. PubMed ID: 3377815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
